Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

Bone Marrow Transplant. 2020 Aug;55(8):1687-1689. doi: 10.1038/s41409-020-0785-9. Epub 2020 Jan 14.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetates
  • Calcineurin Inhibitors* / adverse effects
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Quinazolines

Substances

  • Acetates
  • Calcineurin Inhibitors
  • Quinazolines
  • letermovir